Pharmaceuticals, Biotechnology and Life Sciences
Allergan’s supplemental New Drug Application (sNDA) to expand the approved use of AVYCAZ has gotten the FDA’s approval.
AstraZeneca’s revenues improved over the course of the year, Pascal Soriot, Chief Executive Officer, commenting on the results said on…
Pacific Biosciences of California said in its fourth quarter results announcement that it has had 19% of increase in product, service…
Gilead Sciences has appointed new member to its board of directors, Jacqueline K. Barton who has previously served on Gilead’s Scientific…
Cardinal Health has disposed a business unit for $1.2 billion – its Cardinal Health China – to Shanghai Pharmaceuticals Holding.
A migraine treatment focused biopharmaceutical specialist, Alder BioPharmaceuticals, has closed on Thursday previously announced underwritten offering of $250 million aggregate…
Mylan is launching Efavirenz Tablets USP, 600 mg, in the USA, the first generic version of Bristol-Myers Squibb’s Sustiva, which…
Faron Pharmaceuticals has gotten a patent from European Patent office, for Clever-1 antibodies, the mechanism for the Clevegen, the treatment…
Novo Nordisk has published the results for semaglutide from a study aiming to test the treatment for type 2 diabetes.
Stada has announced the new name to succeed the current CEO Claudio Albrecht in September this year.